Thomas S. Lam - 09 Sep 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ John Vong, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
09 Sep 2024
Net transactions value
+$29.8
Form type
4
Filing time
11 Sep 2024, 17:39:16 UTC
Previous filing
18 Dec 2023
Next filing
12 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $523,058 +28,046 +7.3% $18.65 409,901 09 Sep 2024 Direct
transaction ASTH Common Stock Tax liability $523,028 -11,046 -2.7% $47.35 398,855 09 Sep 2024 Direct F3
holding ASTH Common Stock 1,107,474 09 Sep 2024 By the Thomas and Jeanette Lam 2002 Family Trust
holding ASTH Common Stock 7,132,698 09 Sep 2024 By Allied Physicians of California, a Professional Medical Corporation F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -28,046 -100% $0.000000 0 09 Sep 2024 Common Stock 28,046 $18.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are beneficially owned by Allied Physicians of California, a Professional Medical Corporation, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 These stock options were fully vested and exercisable.
F3 Includes 111,748 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,748 shares, which will vest on November 2, 2024; (ii) 30,000 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; (iii) 30,000 shares, which will vest upon achievement of certain pre-established performance goals; and (iv) 30,000 shares, which will vest upon achievement of certain pre-established performance goals.

Remarks:

Power of Attorney is attached hereto as Exhibit 24.